Lymph node clues may predict immunotherapy success in esophageal cancer
NCT ID NCT07573397
First seen May 11, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study aims to see if a specific type of immune cell (called Tpex) found in cancer-free lymph nodes can predict whether esophageal cancer will completely disappear after immunotherapy given before surgery. Researchers will compare this method to the current standard test (PD-L1 CPS). The study involves 88 adults with esophageal squamous cell carcinoma who are scheduled for surgery and immunotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.